PPP5C
MOLECULAR TARGETprotein phosphatase 5 catalytic subunit
PPP5C (protein phosphatase 5 catalytic subunit) is targeted by 6 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting PPP5C
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | demethyl cantharidin | 3.30 | 26 |
| 2 | cantharidin | 3.18 | 23 |
| 3 | microcystin lr | 2.56 | 12 |
| 4 | calyculin a | 2.20 | 8 |
| 5 | tautomycin | 1.95 | 6 |
| 6 | ninhydrin | 0.69 | 1 |
About PPP5C as a Drug Target
PPP5C (protein phosphatase 5 catalytic subunit) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 6 compounds with documented PPP5C interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
PPP5C inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.